Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block for Pain in Emergency Laparoscopic Cholecystectomy
NCT04767542Phase 3Unknown
- Sponsor
- Bakırköy Dr. Sadi Konuk Research and Training Hospital
- Start
- Mar 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Bakırköy Dr. Sadi Konuk Research and Training Hospital. Primary endpoint: Visual Analogue Scale and Verbal Rating Scale Pain. Status: unknown.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04767542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04767542.